158 results
Page 5 of 8
424B5
ro3eqc ipn
19 Feb 21
Prospectus supplement for primary offering
4:12pm
8-K
l00y28d89p 9eb6my
11 Jan 21
Regulation FD Disclosure
5:05pm
8-K
EX-1.1
7vy5qit
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
424B5
cc1nshn6hitpr8hrouxw
17 Dec 20
Prospectus supplement for primary offering
5:17pm
424B5
k9f 2dbf1tom628ow
15 Dec 20
Prospectus supplement for primary offering
5:04pm
8-K
EX-1.1
6dxd vj8ql
25 Sep 20
Entry into a Material Definitive Agreement
4:54pm
424B5
qmg0bcw6
25 Sep 20
Prospectus supplement for primary offering
4:53pm
8-K
9sui3zzx12k
18 Jun 20
Amendments to Articles of Incorporation or Bylaws
5:01pm
DEFA14A
bhvre64dqs0y92
29 Apr 20
Additional proxy soliciting materials
4:17pm
PRE 14A
um6j098ok 4lf3h
17 Apr 20
Preliminary proxy
4:18pm
8-K
jdely0bl vl
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
8-K
EX-1.1
cl33f pp4
27 Mar 20
Entry into a Material Definitive Agreement
5:19pm
424B5
aa5ss7c oy6fhbrz
27 Mar 20
Prospectus supplement for primary offering
5:19pm
S-8
EX-5.1
gl3o85yy x6
26 Mar 20
Registration of securities for employees
5:26pm
S-8
EX-23.1
qcf8gsemcnmtm9f9s
26 Mar 20
Registration of securities for employees
5:26pm
S-8
u9a2l9iqwn
26 Mar 20
Registration of securities for employees
5:26pm